| __timestamp | AbbVie Inc. | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 4426000000 | 9216000000 |
| Thursday, January 1, 2015 | 4500000000 | 8296000000 |
| Friday, January 1, 2016 | 5833000000 | 10044000000 |
| Sunday, January 1, 2017 | 7040000000 | 11560000000 |
| Monday, January 1, 2018 | 7718000000 | 10558000000 |
| Tuesday, January 1, 2019 | 7439000000 | 9351000000 |
| Wednesday, January 1, 2020 | 15387000000 | 8933000000 |
| Friday, January 1, 2021 | 17446000000 | 8284000000 |
| Saturday, January 1, 2022 | 17414000000 | 7952000000 |
| Sunday, January 1, 2023 | 20415000000 | 8200000000 |
| Monday, January 1, 2024 | 16904000000 | 8480000000 |
Unlocking the unknown
In the competitive landscape of pharmaceuticals, cost efficiency is paramount. From 2014 to 2023, AbbVie Inc. and Teva Pharmaceutical Industries Limited have showcased contrasting trends in their cost of revenue. AbbVie Inc. has seen a remarkable increase of approximately 361% in its cost of revenue, peaking in 2023. This growth reflects its aggressive expansion and investment in new drug development. In contrast, Teva's cost of revenue has decreased by about 14% over the same period, indicating a strategic shift towards cost optimization and efficiency.
These trends underscore the diverse strategies employed by these pharmaceutical giants in navigating the industry's challenges.
Cost of Revenue Comparison: AbbVie Inc. vs Merck & Co., Inc.
AbbVie Inc. vs Sanofi: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: AbbVie Inc. and Zoetis Inc.
Cost of Revenue Comparison: AbbVie Inc. vs Dr. Reddy's Laboratories Limited
Cost of Revenue: Key Insights for AbbVie Inc. and Vericel Corporation
Cost Insights: Breaking Down Takeda Pharmaceutical Company Limited and Teva Pharmaceutical Industries Limited's Expenses
Cost of Revenue: Key Insights for Teva Pharmaceutical Industries Limited and Neurocrine Biosciences, Inc.
Teva Pharmaceutical Industries Limited vs Walgreens Boots Alliance, Inc.: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: Teva Pharmaceutical Industries Limited and Jazz Pharmaceuticals plc
Cost Insights: Breaking Down Teva Pharmaceutical Industries Limited and Grifols, S.A.'s Expenses
Cost of Revenue: Key Insights for Teva Pharmaceutical Industries Limited and Vericel Corporation
Cost of Revenue Comparison: Teva Pharmaceutical Industries Limited vs Iovance Biotherapeutics, Inc.